Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of ProKidney Corp (NASDAQ: PROK) closed at $2.82 in the last session, up 1.81% from day before closing price of $2.77. In other words, the price has increased by $1.81 from its previous closing price. On the day, 1.32 million shares were traded.
Ratios:
We take a closer look at PROK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.96 and its Current Ratio is at 10.96.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.Guggenheim initiated its Buy rating on September 10, 2024, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 08 ’25 when Weber Darin J. sold 103,480 shares for $3.02 per share. The transaction valued at 312,510 led to the insider holds 0 shares of the business.
DARIN J WEBER bought 103,480 shares of PROK for $62,761 on Jul 08 ’25. On Apr 22 ’25, another insider, Control Empresarial de Capital, who serves as the Add’l Rep. Persons-see Ex.99-1 of the company, bought 387,393 shares for $0.71 each. As a result, the insider paid 276,366 and bolstered with 73,842,723 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2662.71.
Stock Price History:
Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is 58.71%, while the 200-Day Moving Average is calculated to be 88.28%.
Shares Statistics:
A total of 129.54M shares are outstanding, with a floating share count of 97.12M. Insiders hold about 27.21% of the company’s shares, while institutions hold 41.01% stake in the company.
